Ultrawell Pharma Private Limited
About Ultrawell Pharma Private Limited
Data last updated:
Ultrawell Pharma Private Limited is a private limited company based in Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 25 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2019PTC356700. Its GSTIN is 07AAFCI4470G1ZL (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Icon Lifescience Private Limited. It is led by directors Subhash Kumar Mishra and Mona Mishra.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Rajendra Thakur A – 635 – C G/F New Ashok Nagar, Delhi, India – 110096.
Company details
Contact details
Ultrawell Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressRajendra Thakur A – 635 – C G/F New Ashok Nagar, Delhi, India – 110096
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Ultrawell Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ultrawell Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ultrawell Pharma Private Limited, buy the company report.
Financials of Ultrawell Pharma Private Limited
FY 2022 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ultrawell Pharma Private Limited, buy the company report.
Board of directors of Ultrawell Pharma Private Limited
Ultrawell Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhash Kumar Mishra | Director | 25 Oct 2019 | 7 Years 0 Months | Current |
| Mona Mishra | Director | 25 Oct 2019 | 7 Years 0 Months | Current |
Auditor
Ultrawell Pharma Private Limited is audited by CHARLES & CHANDRASEKAR for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHARLES & CHANDRASEKAR | FY 2020 | 005759S |
Shareholding
The shareholding of Ultrawell Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ultrawell Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ultrawell Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ultrawell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ultrawell Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCI4470G1ZL | Delhi | Active | 12 Dec 2019 |
To see the full GST registrations and return filing status of Ultrawell Pharma Private Limited, buy the company report.
Recent activity
Ultrawell Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Mona Mishra was appointed as Director on 25 Oct 2019.
Frequently asked questions
Ultrawell Pharma is an active private limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 25 October 2019 (7+ years old) and is registered under CIN U51397DL2019PTC356700.
Ultrawell Pharma has 2 current directors:
- Subhash Kumar Mishra - Director
- Mona Mishra - Director
The latest financial statements of Ultrawell Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Ultrawell Pharma is 07AAFCI4470G1ZL, registered in Delhi.
The CIN (Corporate Identification Number) of Ultrawell Pharma is U51397DL2019PTC356700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ultrawell Pharma was incorporated on 25 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Mona Mishra was appointed as Director on 25 Oct 2019. Subhash Kumar Mishra was appointed as Director on 25 Oct 2019.
The registered office of Ultrawell Pharma is at Rajendra Thakur A – 635 – C GF New Ashok Nagar, Delhi, India – 110096.
Ultrawell Pharma operates in the healthcare industry, in the medical equipment retail and distribution segment.
Yes. Ultrawell Pharma was formerly known as Icon Lifescience Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
